Prediction of the effect on antihyperglycaemic action of sitagliptin by plasma active form glucagon-like peptide-1

Figure 1 Baseline measurements of homeostasis model assessment of insulin resistance, HOMA-β, insulin, high sensitive C reactive protein, glucagon, and PI/insulin resistance index ratio. Patients’ insulin resistance, insulin and glucagon secretion, and hsCRP at baseline is stratified against plasma active GLP-1 level. Data has been presented by boxplot. ¹Mean statistical significance P < 0.05. GLP-1: Glucagon-like peptide-1; hsCRP: High sensitive C reactive protein.